Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Kohl’s Q2 2024 Earnings Highlights: Declining Sales, Beauty Remains a Hot Spot

by Team Lumida
August 29, 2024
in Equities
Reading Time: 10 mins read
A A
0
Kohl’s Q2 2024 Earnings Highlights: Declining Sales, Beauty Remains a Hot Spot
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Top Takeaways

  1. Q2 sales declined 4.2% year-over-year, but earnings increased 13% due to gross margin expansion and expense management.
  2. Sephora partnership continues to drive strong growth, with total beauty sales up 45% and comparable beauty sales up low-teens.
  3. New initiatives like Babies “R” Us partnership and expansion of impulse queuing lines expected to drive incremental sales in second half.
  4. Core apparel and footwear business remains challenged, with management taking actions to improve product assortment and marketing.
  5. Full year guidance lowered on sales but raised on earnings per share, reflecting ongoing macro challenges and operational discipline.

Kohl’s Q2 Results Show Earnings Growth Despite Sales Decline

Kohl’s reported mixed Q2 2024 results, with sales declining but earnings growing due to margin expansion and cost control. Net sales decreased 4.2% year-over-year to $3.7 billion, while earnings per share increased 13% to $0.59.

“Although we are disappointed with our second quarter sales, we continue to execute well operationally, enabling us to deliver a 13% increase in earnings, driven by gross margin expansion and strong inventory and expense management.” – Tom Kingsbury, CEO

Main Themes

  • Guidance: Full year net sales outlook lowered to -4% to -6% vs. prior -2% to -4%; EPS guidance raised to $1.75-$2.25 from $1.25-$1.85
  • Economy: Middle-income consumers remain pressured by inflation and high interest rates
  • New Initiatives: Babies “R” Us partnership launched, expansion of impulse queuing lines
  • Product Performance: Strong growth in Sephora, home decor, gifting; weakness in core apparel/footwear
  • Operational Discipline: Inventory down 9% YoY, SG&A expenses down 4.2%

Key Insights

  • Sephora at Kohl’s continues to be a key growth driver, with total beauty sales up 45% YoY and comparable beauty sales growing low-teens
  • 40% of Sephora at Kohl’s customers are new to Kohl’s, representing significant customer acquisition
  • Approximately 35% of Sephora baskets include other Kohl’s products, primarily women’s, juniors, impulse and accessories
  • New initiatives like Babies “R” Us and expanded impulse queuing lines expected to drive incremental sales in second half

Market Opportunity

Kohl’s is working to broaden its reach with young families through the Babies “R” Us partnership. The company is opening 200 baby shops featuring thousands of products across baby gear, furniture and accessories. This expands Kohl’s addressable market in the baby category and complements its existing children’s business.

Customer Behaviors

Kohl’s noted that middle-income consumers are exhibiting more discretion in spending, leading to smaller average basket sizes. However, the company saw an increase in overall transactions and improved conversion rates in Q2, indicating its product newness is resonating with customers.

“We attracted more new customers to Kohl’s and experienced an increase in overall transactions, both of which are positive developments. At the same time however, our customers exhibited more discretion in their spending, which pressured overall sales.” – Tom Kingsbury, CEO

Capital Expenditures

  • Year-to-date capital expenditures: $239 million, down significantly from $338 million last year
  • Full year 2024 CapEx planned at approximately $500 million
  • Key investments: 350 impulse queuing lines, 140 Sephora small shop openings, 200 Babies “R” Us shops, 6 new store openings

Economy Insights

Management highlighted ongoing macroeconomic challenges impacting consumer spending:

“Inflation and high interest rates continue to pressure spending, especially among our middle-income consumers. We are seeing the clearest evidence of this in the performance of our core apparel and footwear offering, which experienced broad softness in the quarter.” – Tom Kingsbury, CEO

Industry Insights

Kohl’s results and commentary suggest ongoing challenges for mid-tier department stores and apparel retailers targeting middle-income consumers. The success of Sephora shops indicates beauty remains a bright spot in retail. The expansion into baby products through Babies “R” Us could present opportunities for other retailers to diversify their offerings and attract young families.

Key Metrics

Financial Metrics

  • Net sales: $3.7 billion, down 4.2% YoY
  • Comparable sales: -5.1%
  • Gross margin: 39.6%, up 59 basis points YoY
  • SG&A expenses: $1.2 billion, down 4.2% YoY
  • Operating margin: 3.4% to 3.8% (full year guidance)
  • EPS: $0.59, up 13% YoY

KPIs

  • Inventory: Down 9% YoY
  • Digital sales: Outperformed store sales, but both declined YoY
  • New customer acquisition: 40% of Sephora customers new to Kohl’s
  • Sephora total beauty sales: Up 45% YoY
  • Sephora comparable sales: Up low-teens %

Competitive Differentiators

  1. Sephora partnership driving strong beauty sales growth and new customer acquisition
  2. Expanded presence in baby category through Babies “R” Us partnership
  3. Growing home decor, gifting, and impulse businesses
  4. Operational discipline in inventory and expense management
  5. Omnichannel capabilities with digital sales outperforming store sales

Key Risks

  1. Ongoing weakness in core apparel and footwear business
  2. Pressure on middle-income consumers from inflation and high interest rates
  3. Highly promotional retail environment, particularly expected for holiday season
  4. Potential impact of CFPB late fee rule on credit business revenue (currently excluded from guidance)
  5. Execution risk in turning around underperforming categories like jewelry and legacy home

Analyst Q&A Focus

Analysts focused on:

  1. Performance of Sephora shops and cross-shopping behavior
  2. Early reads on Babies “R” Us partnership
  3. Outlook for promotional environment in second half
  4. Opportunities to improve core apparel and footwear business
  5. Drivers of increased margin leverage in guidance despite lower sales

Kohl’s Summary:

Kohl’s Q2 results reflect the ongoing challenges facing mid-tier retailers in the current economic environment. While the company’s partnership with Sephora continues to drive growth and new customer acquisition, weakness in core apparel and footwear is offsetting these gains. Management is focused on improving product assortment, amplifying value messaging, and capitalizing on new initiatives like Babies “R” Us to drive sales in the back half of the year. The company’s operational discipline and focus on inventory management are supporting profitability despite top-line pressures. Investors should watch for signs of improvement in core categories and the performance of new initiatives as indicators of Kohl’s ability to return to sustainable growth.

Tags: EARNINGSKohl
Previous Post

Chewy Q2 2024 Earnings Highlights: Strong Execution and Margin Expansion

Next Post

Nvidia’s Cutting-Edge Chips: The Future of Tech Innovation

Recommended For You

Sprouts Plunges as Much as 23% After Cutting Its Outlook to a 1.7% Comparable Sales Decline, Blaming a Lettuce Outbreak and Squeezed Shoppers

by Team Lumida
2 hours ago

Sprouts fell up to 23% after hours after cutting its 2026 outlook to a 1.7% comparable sales decline as the cyclospora outbreak and affordability bite.

Read more

Waymo’s Losses Widen to $2.05 Billion While Other Bets Brings In Just 0.3% of Alphabet’s Sales, Even as It Hits 300 Million Driverless Miles

by Team Lumida
2 hours ago

Alphabet’s Other Bets, which houses Waymo, lost $2.05 billion in Q3 on just $372 million of revenue as free cash flow turned negative.

Read more

FedEx Beats With 28% EPS Growth in Its First Report Without Freight, but a $6.33 Holiday-Quarter EPS Guide Below the $6.58 Consensus Sends Shares Lower

by Team Lumida
2 hours ago

FedEx beat on revenue and EPS, but a soft holiday-quarter profit outlook on higher trucking and fuel costs pushed shares down over 2% after hours.

Read more

Alphabet Sinks Nearly 10% After Its First Top- and Bottom-Line Miss in Almost Four Years, as AI Mode Weighs on Search Ads and 2027 Capex Heads Above $300 Billion

by Team Lumida
2 hours ago

Alphabet fell about 10% after hours as ad-heavy services revenue missed by $2.2 billion, EPS fell 7% and free cash flow sank to minus $9.07 billion.

Read more

Frontier Raises Average Fares 71% to $67.82 as Its Fuel Bill Soars 82%, and the Stock Climbs on a Forecast for a Possible Fourth-Quarter Profit

by Team Lumida
18 hours ago

Frontier lifted average fares 71% and carried 18% more passengers, but an 82% jump in fuel costs widened its loss to $104 million.

Read more

The Magnificent Seven Is Splitting Apart: Correlations Hit a Decade-Plus Low as Apple Leads With a 28% Gain and Only Two Members Beat the S&P 500

by Team Lumida
18 hours ago

The Magnificent Seven’s average correlation has fallen to its lowest in over a decade, with Apple and Nvidia the only members beating the S&P 500.

Read more

Peltz’s Trian Offers $1.4 Billion to Take Wendy’s Private at $7.35 a Share, Sending the Stock Up About 15% After a 65% Two-Year Slide

by Team Lumida
18 hours ago

Trian and partners offered $7.35 a share in cash for Wendy’s, a 20% premium, after six straight quarters of falling same-store sales.

Read more

Drone Stocks Have Fallen 40% Since January, and a Midterm Blue Wave Could Put $55 Billion of Pentagon Autonomy Funding at Risk

by Team Lumida
18 hours ago

Drone stocks are down 40% from January’s peak as investors fear a Democratic win could block $55 billion of reconciliation-funded autonomy spending.

Read more

Boston Scientific Cuts Its Outlook Again and Sees Fourth-Quarter Sales Falling as Much as 3%, With August’s Cyberattack Still Weighing

by Team Lumida
18 hours ago

Boston Scientific now sees 2026 sales growth of about 4.25% and a fourth-quarter sales decline as an August cyberattack keeps disrupting operations.

Read more

GE Vernova Bets $9 Billion on Trench Group’s Grid Gear as Orders Nearly Double to $29.3 Billion and Backlog Nears $200 Billion

by Team Lumida
18 hours ago

GE Vernova will buy Trench Group for $9 billion, raised its 2026 revenue outlook and doubled its buyback to $20 billion after a strong quarter.

Read more
Next Post
a computer chip with the letter a on top of it

Nvidia's Cutting-Edge Chips: The Future of Tech Innovation

Dell Shares Soar: AI Server Demand Fuels Record-Breaking Quarter!”

Dell Shares Soar: AI Server Demand Fuels Record-Breaking Quarter!"

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

TotalEnergies Acquires 25% Stake in Chevron-Operated U.S. Offshore Exploration Blocks

TotalEnergies Acquires 25% Stake in Chevron-Operated U.S. Offshore Exploration Blocks

June 16, 2025
Medical AI Has a ‘Proof Problem’: Only 2.4% of FDA-Approved Devices Backed by Trial Data; Nvidia, Microsoft, Google Face Regulatory Headwinds

Medical AI Has a ‘Proof Problem’: Only 2.4% of FDA-Approved Devices Backed by Trial Data; Nvidia, Microsoft, Google Face Regulatory Headwinds

September 18, 2026
person sitting while using laptop computer and green stethoscope near

Healthcare Roundup: Medicare Advantage Gets a $13B Boost, Drug Tariffs Hit 100%, and Wegovy Goes Discount

April 9, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018